Literature DB >> 15207441

Maximizing outcome of dementia treatment: the role of nutrition.

B Steen1.   

Abstract

The dementia syndromes are multifactorial regarding etiology, prevention, diagnosis,therapy, and rehabilitation, which include genetics, histopathology, biochemistry as well as sociopsychology, clinical medicine and caring sciences. This review concentrates on nutritional aspects. This includes body composition, where sarcopenia and water deprivations are important issues. Body weight and body water decrease with age which together with the well-known deterioration of thirst perception in old age may give rise to e.g., circulatory collapse and confusion, which is such a common symptom in the elderly not the least in demented patients. We have shown that an improved meal environment in nursing home patients markedly improves the psychosocial and nutritional situation. Aspects on feeding behavior have been shown to be important as well. Epidemiologically, recent 18-year longitudinal data from the gerontological and geriatric population studies in Göteborg, Sweden(H70) suggest that overweight at high ages is a risk factor for dementia, particularly Alzheimer's disease, in women. Furthermore, overweight and obesity are important contributors to the presence of white matter lesions in the elderly.

Entities:  

Mesh:

Year:  2004        PMID: 15207441     DOI: 10.1016/j.archger.2004.04.063

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr Suppl        ISSN: 0924-7947


  2 in total

1.  [Aspects of the report of the IQWiG (Institute for Quality and Cost Effectiveness in Public Health) " Cholinesterase inhibitors in Alzheimer's dementia"].

Authors:  Manfred Gogol; Dieter Lüttje; Hansjörg Werner
Journal:  Z Gerontol Geriatr       Date:  2007-06       Impact factor: 1.281

2.  Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment.

Authors:  Suzanne M de la Monte; Ming Tong; Margot Lawton; Lisa Longato
Journal:  Mol Neurodegener       Date:  2009-12-24       Impact factor: 14.195

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.